<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="ca">
	<id>https://rthwiki.iconcologia.net/index.php?action=history&amp;feed=atom&amp;title=Criteris_d%E2%80%99inclusi%C3%B3_de_l%E2%80%99RTH_ICO-ICS</id>
	<title>Criteris d’inclusió de l’RTH ICO-ICS - Historial de revisió</title>
	<link rel="self" type="application/atom+xml" href="https://rthwiki.iconcologia.net/index.php?action=history&amp;feed=atom&amp;title=Criteris_d%E2%80%99inclusi%C3%B3_de_l%E2%80%99RTH_ICO-ICS"/>
	<link rel="alternate" type="text/html" href="https://rthwiki.iconcologia.net/index.php?title=Criteris_d%E2%80%99inclusi%C3%B3_de_l%E2%80%99RTH_ICO-ICS&amp;action=history"/>
	<updated>2026-05-14T12:23:13Z</updated>
	<subtitle>Historial de revisió per a aquesta pàgina del wiki</subtitle>
	<generator>MediaWiki 1.44.2</generator>
	<entry>
		<id>https://rthwiki.iconcologia.net/index.php?title=Criteris_d%E2%80%99inclusi%C3%B3_de_l%E2%80%99RTH_ICO-ICS&amp;diff=1849&amp;oldid=prev</id>
		<title>Jmescriba a 16:16, 24 feb 2026</title>
		<link rel="alternate" type="text/html" href="https://rthwiki.iconcologia.net/index.php?title=Criteris_d%E2%80%99inclusi%C3%B3_de_l%E2%80%99RTH_ICO-ICS&amp;diff=1849&amp;oldid=prev"/>
		<updated>2026-02-24T16:16:44Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;ca&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Versió més antiga&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revisió del 16:16, 24 feb 2026&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l2&quot;&gt;Línia 2:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Línia 2:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;==&amp;lt;big&amp;gt;Definició de cas&amp;lt;/big&amp;gt;==&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;==&amp;lt;big&amp;gt;Definició de cas&amp;lt;/big&amp;gt;==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;S’inclouen a l’RTH els tumors diagnosticats i/o tractats al centre de l’RTH en el període d’estudi. Criteris d’inclusió:&amp;lt;ref name=&quot;:0&quot;&amp;gt;International Agency for Research on Cancer. &#039;&#039;Standards and Guidelines for Cancer Registration in Europe. The ENCR Recommendations.&#039;&#039; Vol I. (Tyczynski J, Démaret E, Parkin D, ed.). IARC Technical Publication No. 40; 2003. &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;http&lt;/del&gt;://&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;www&lt;/del&gt;.&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&amp;amp;#x20;&lt;/del&gt;iarc.&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;fr&lt;/del&gt;/&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;en&lt;/del&gt;/&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;publications&lt;/del&gt;/&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;pdfs&lt;/del&gt;-&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;online/treport&lt;/del&gt;-&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;pub/treport&lt;/del&gt;-&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;pub40/index.php&lt;/del&gt;&amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;:1&quot;&amp;gt;Martos C, Crocetti E, Visser O, Rous B, Cancer Data Quality Checks Working Group. &#039;&#039;A Proposal on Cancer Data Quality Checks : One Common Procedure for European Cancer Registries&#039;&#039;. European Network of Cancer Registries; 2018. doi:10.2760/429053&amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;:8&quot;&amp;gt;International Agency for Research on Cancer, World Health Organization, International Association of Cancer Registries. &#039;&#039;Cancer Registration: Principles and Methods&#039;&#039;. (Jensen O, Parkin D, Maclennan R, Muir C, Skeet R, ed.). IARC Scientific Publications No, 95; 1991. https://publications.iarc.fr/Book-And-Report-Series/Iarc-Scientific-Publications/&amp;amp;#x20;Cancer-Registration-Principles-And-Methods-1991&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;S’inclouen a l’RTH els tumors diagnosticats i/o tractats al centre de l’RTH en el període d’estudi. Criteris d’inclusió:&amp;lt;ref name=&quot;:0&quot;&amp;gt;International Agency for Research on Cancer. &#039;&#039;Standards and Guidelines for Cancer Registration in Europe. The ENCR Recommendations.&#039;&#039; Vol I. (Tyczynski J, Démaret E, Parkin D, ed.). IARC Technical Publication No. 40; 2003.&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;https&lt;/ins&gt;://&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;publications&lt;/ins&gt;.iarc.&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;who.int&lt;/ins&gt;/&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;Book-And-Report-Series&lt;/ins&gt;/&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;Iarc-Technical-Publications&lt;/ins&gt;/&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;Standards&lt;/ins&gt;-&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;And-Guidelines-For-Cancer-Registration-In&lt;/ins&gt;-&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;Europe&lt;/ins&gt;-&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;2003&lt;/ins&gt;&amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;:1&quot;&amp;gt;Martos C, Crocetti E, Visser O, Rous B, Cancer Data Quality Checks Working Group. &#039;&#039;A Proposal on Cancer Data Quality Checks : One Common Procedure for European Cancer Registries&#039;&#039;. European Network of Cancer Registries; 2018. doi:10.2760/429053&amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;:8&quot;&amp;gt;International Agency for Research on Cancer, World Health Organization, International Association of Cancer Registries. &#039;&#039;Cancer Registration: Principles and Methods&#039;&#039;. (Jensen O, Parkin D, Maclennan R, Muir C, Skeet R, ed.). IARC Scientific Publications No, 95; 1991. https://publications.iarc.fr/Book-And-Report-Series/Iarc-Scientific-Publications/&amp;amp;#x20;Cancer-Registration-Principles-And-Methods-1991&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;#Histologies amb comportament maligne (/3, /6 o /9) independentment de la localització tumoral.&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;#Histologies amb comportament maligne (/3, /6 o /9) independentment de la localització tumoral.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Jmescriba</name></author>
	</entry>
	<entry>
		<id>https://rthwiki.iconcologia.net/index.php?title=Criteris_d%E2%80%99inclusi%C3%B3_de_l%E2%80%99RTH_ICO-ICS&amp;diff=1848&amp;oldid=prev</id>
		<title>Jmescriba a 15:58, 24 feb 2026</title>
		<link rel="alternate" type="text/html" href="https://rthwiki.iconcologia.net/index.php?title=Criteris_d%E2%80%99inclusi%C3%B3_de_l%E2%80%99RTH_ICO-ICS&amp;diff=1848&amp;oldid=prev"/>
		<updated>2026-02-24T15:58:03Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;ca&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Versió més antiga&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revisió del 15:58, 24 feb 2026&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l90&quot;&gt;Línia 90:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Línia 90:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;==&amp;lt;big&amp;gt;Definició de tumors múltiples: normes de registre&amp;lt;/big&amp;gt;==&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;==&amp;lt;big&amp;gt;Definició de tumors múltiples: normes de registre&amp;lt;/big&amp;gt;==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;IMPORTANT!!: &#039;&#039;&#039;Els tumors urotelials múltiples de les vies urinàries (C65-C68), els tumors del Sistema Nerviós Central múltiples i les neoplàsies hematològiques múltiples segueixen unes recomanacions especifiques d&#039;enregistrament que podeu consultar a la pàgina web de la ENCR.   &amp;lt;br /&amp;gt;&#039;&#039;&#039;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;IMPORTANT!!: &#039;&#039;&#039;Els tumors urotelials múltiples de les vies urinàries (C65-C68), els tumors del Sistema Nerviós Central múltiples i les neoplàsies hematològiques múltiples segueixen unes recomanacions especifiques d&#039;enregistrament que podeu consultar a la pàgina web de la &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;[https://www.encr.eu/&lt;/ins&gt;ENCR&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;-Recommendations ENCR]&lt;/ins&gt;.   &amp;lt;br /&amp;gt;&#039;&#039;&#039;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;L’RTH registra tumors i els assigna un identificador. L’identificador de pacient permet saber si un pacient presenta un tumor o més (tumors múltiples). Els tumors múltiples segueixen la normativa de la IARC:&amp;lt;ref name=&amp;quot;:12&amp;quot;&amp;gt;International Agency for Research on Cancer, World Health Organization, International Association of Cancer Registries, European Network of Cancer Registries. &amp;#039;&amp;#039;International Rules for Multiple Primary Cancers (ICD-O Third Edition)&amp;#039;&amp;#039;. International Agency for the Research on Cancer; 2004. http://www.iacr.com.fr/images/doc/MPrules_&amp;amp;#x20;july2004.pdf&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;L’RTH registra tumors i els assigna un identificador. L’identificador de pacient permet saber si un pacient presenta un tumor o més (tumors múltiples). Els tumors múltiples segueixen la normativa de la IARC:&amp;lt;ref name=&amp;quot;:12&amp;quot;&amp;gt;International Agency for Research on Cancer, World Health Organization, International Association of Cancer Registries, European Network of Cancer Registries. &amp;#039;&amp;#039;International Rules for Multiple Primary Cancers (ICD-O Third Edition)&amp;#039;&amp;#039;. International Agency for the Research on Cancer; 2004. http://www.iacr.com.fr/images/doc/MPrules_&amp;amp;#x20;july2004.pdf&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Jmescriba</name></author>
	</entry>
	<entry>
		<id>https://rthwiki.iconcologia.net/index.php?title=Criteris_d%E2%80%99inclusi%C3%B3_de_l%E2%80%99RTH_ICO-ICS&amp;diff=1840&amp;oldid=prev</id>
		<title>Jmescriba a 15:21, 23 feb 2026</title>
		<link rel="alternate" type="text/html" href="https://rthwiki.iconcologia.net/index.php?title=Criteris_d%E2%80%99inclusi%C3%B3_de_l%E2%80%99RTH_ICO-ICS&amp;diff=1840&amp;oldid=prev"/>
		<updated>2026-02-23T15:21:16Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;ca&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Versió més antiga&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revisió del 15:21, 23 feb 2026&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l90&quot;&gt;Línia 90:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Línia 90:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;==&amp;lt;big&amp;gt;Definició de tumors múltiples: normes de registre&amp;lt;/big&amp;gt;==&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;==&amp;lt;big&amp;gt;Definició de tumors múltiples: normes de registre&amp;lt;/big&amp;gt;==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;IMPORTANT !!: &#039;&#039;&#039;Els tumors urotelials múltiples de les vies urinàries (C65-C68), els tumors del Sistema Nerviós Central múltiples i les neoplàsies hematològiques múltiples segueixen unes recomanacions especifiques d&#039;enregistrament que podeu consultar a la pàgina web de la ENCR.   &amp;lt;br /&amp;gt;&#039;&#039;&#039;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;IMPORTANT!!: &#039;&#039;&#039;Els tumors urotelials múltiples de les vies urinàries (C65-C68), els tumors del Sistema Nerviós Central múltiples i les neoplàsies hematològiques múltiples segueixen unes recomanacions especifiques d&#039;enregistrament que podeu consultar a la pàgina web de la ENCR.   &amp;lt;br /&amp;gt;&#039;&#039;&#039;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;L’RTH registra tumors i els assigna un identificador. L’identificador de pacient permet saber si un pacient presenta un tumor o més (tumors múltiples). Els tumors múltiples segueixen la normativa de la IARC:&amp;lt;ref name=&amp;quot;:12&amp;quot;&amp;gt;International Agency for Research on Cancer, World Health Organization, International Association of Cancer Registries, European Network of Cancer Registries. &amp;#039;&amp;#039;International Rules for Multiple Primary Cancers (ICD-O Third Edition)&amp;#039;&amp;#039;. International Agency for the Research on Cancer; 2004. http://www.iacr.com.fr/images/doc/MPrules_&amp;amp;#x20;july2004.pdf&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;L’RTH registra tumors i els assigna un identificador. L’identificador de pacient permet saber si un pacient presenta un tumor o més (tumors múltiples). Els tumors múltiples segueixen la normativa de la IARC:&amp;lt;ref name=&amp;quot;:12&amp;quot;&amp;gt;International Agency for Research on Cancer, World Health Organization, International Association of Cancer Registries, European Network of Cancer Registries. &amp;#039;&amp;#039;International Rules for Multiple Primary Cancers (ICD-O Third Edition)&amp;#039;&amp;#039;. International Agency for the Research on Cancer; 2004. http://www.iacr.com.fr/images/doc/MPrules_&amp;amp;#x20;july2004.pdf&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Jmescriba</name></author>
	</entry>
	<entry>
		<id>https://rthwiki.iconcologia.net/index.php?title=Criteris_d%E2%80%99inclusi%C3%B3_de_l%E2%80%99RTH_ICO-ICS&amp;diff=1836&amp;oldid=prev</id>
		<title>Jmescriba a 14:11, 23 feb 2026</title>
		<link rel="alternate" type="text/html" href="https://rthwiki.iconcologia.net/index.php?title=Criteris_d%E2%80%99inclusi%C3%B3_de_l%E2%80%99RTH_ICO-ICS&amp;diff=1836&amp;oldid=prev"/>
		<updated>2026-02-23T14:11:43Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;ca&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Versió més antiga&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revisió del 14:11, 23 feb 2026&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l90&quot;&gt;Línia 90:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Línia 90:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;==&amp;lt;big&amp;gt;Definició de tumors múltiples: normes de registre&amp;lt;/big&amp;gt;==&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;==&amp;lt;big&amp;gt;Definició de tumors múltiples: normes de registre&amp;lt;/big&amp;gt;==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;IMPORTANT !!: &#039;&#039;&#039;Els tumors urotelials múltiples de les vies urinàries (C65-C68), els tumors &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;múltiples &lt;/del&gt;del Sistema Nerviós Central i les neoplàsies hematològiques múltiples segueixen unes recomanacions especifiques d&#039;enregistrament que podeu consultar a la pàgina web de la ENCR.   &amp;lt;br /&amp;gt;&#039;&#039;&#039;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;IMPORTANT !!: &#039;&#039;&#039;Els tumors urotelials múltiples de les vies urinàries (C65-C68), els tumors del Sistema Nerviós Central &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;múltiples &lt;/ins&gt;i les neoplàsies hematològiques múltiples segueixen unes recomanacions especifiques d&#039;enregistrament que podeu consultar a la pàgina web de la ENCR.   &amp;lt;br /&amp;gt;&#039;&#039;&#039;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;L’RTH registra tumors i els assigna un identificador. L’identificador de pacient permet saber si un pacient presenta un tumor o més (tumors múltiples). Els tumors múltiples segueixen la normativa de la IARC:&amp;lt;ref name=&amp;quot;:12&amp;quot;&amp;gt;International Agency for Research on Cancer, World Health Organization, International Association of Cancer Registries, European Network of Cancer Registries. &amp;#039;&amp;#039;International Rules for Multiple Primary Cancers (ICD-O Third Edition)&amp;#039;&amp;#039;. International Agency for the Research on Cancer; 2004. http://www.iacr.com.fr/images/doc/MPrules_&amp;amp;#x20;july2004.pdf&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;L’RTH registra tumors i els assigna un identificador. L’identificador de pacient permet saber si un pacient presenta un tumor o més (tumors múltiples). Els tumors múltiples segueixen la normativa de la IARC:&amp;lt;ref name=&amp;quot;:12&amp;quot;&amp;gt;International Agency for Research on Cancer, World Health Organization, International Association of Cancer Registries, European Network of Cancer Registries. &amp;#039;&amp;#039;International Rules for Multiple Primary Cancers (ICD-O Third Edition)&amp;#039;&amp;#039;. International Agency for the Research on Cancer; 2004. http://www.iacr.com.fr/images/doc/MPrules_&amp;amp;#x20;july2004.pdf&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Jmescriba</name></author>
	</entry>
	<entry>
		<id>https://rthwiki.iconcologia.net/index.php?title=Criteris_d%E2%80%99inclusi%C3%B3_de_l%E2%80%99RTH_ICO-ICS&amp;diff=1835&amp;oldid=prev</id>
		<title>Jmescriba a 14:10, 23 feb 2026</title>
		<link rel="alternate" type="text/html" href="https://rthwiki.iconcologia.net/index.php?title=Criteris_d%E2%80%99inclusi%C3%B3_de_l%E2%80%99RTH_ICO-ICS&amp;diff=1835&amp;oldid=prev"/>
		<updated>2026-02-23T14:10:21Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;ca&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Versió més antiga&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revisió del 14:10, 23 feb 2026&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l90&quot;&gt;Línia 90:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Línia 90:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;==&amp;lt;big&amp;gt;Definició de tumors múltiples: normes de registre&amp;lt;/big&amp;gt;==&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;==&amp;lt;big&amp;gt;Definició de tumors múltiples: normes de registre&amp;lt;/big&amp;gt;==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;IMPORTANT !!: &#039;&#039;&#039;Els tumors urotelials múltiples de les vies urinàries (C65-C68), els tumors múltiples del Sistema Nerviós Central i les neoplàsies hematològiques múltiples segueixen unes &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;recomanaciones &lt;/del&gt;especifiques d&#039;enregistrament que podeu consultar a la pàgina web de la ENCR.   &amp;lt;br /&amp;gt;&#039;&#039;&#039;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;IMPORTANT !!: &#039;&#039;&#039;Els tumors urotelials múltiples de les vies urinàries (C65-C68), els tumors múltiples del Sistema Nerviós Central i les neoplàsies hematològiques múltiples segueixen unes &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;recomanacions &lt;/ins&gt;especifiques d&#039;enregistrament que podeu consultar a la pàgina web de la ENCR.   &amp;lt;br /&amp;gt;&#039;&#039;&#039;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;L’RTH registra tumors i els assigna un identificador. L’identificador de pacient permet saber si un pacient presenta un tumor o més (tumors múltiples). Els tumors múltiples segueixen la normativa de la IARC:&amp;lt;ref name=&amp;quot;:12&amp;quot;&amp;gt;International Agency for Research on Cancer, World Health Organization, International Association of Cancer Registries, European Network of Cancer Registries. &amp;#039;&amp;#039;International Rules for Multiple Primary Cancers (ICD-O Third Edition)&amp;#039;&amp;#039;. International Agency for the Research on Cancer; 2004. http://www.iacr.com.fr/images/doc/MPrules_&amp;amp;#x20;july2004.pdf&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;L’RTH registra tumors i els assigna un identificador. L’identificador de pacient permet saber si un pacient presenta un tumor o més (tumors múltiples). Els tumors múltiples segueixen la normativa de la IARC:&amp;lt;ref name=&amp;quot;:12&amp;quot;&amp;gt;International Agency for Research on Cancer, World Health Organization, International Association of Cancer Registries, European Network of Cancer Registries. &amp;#039;&amp;#039;International Rules for Multiple Primary Cancers (ICD-O Third Edition)&amp;#039;&amp;#039;. International Agency for the Research on Cancer; 2004. http://www.iacr.com.fr/images/doc/MPrules_&amp;amp;#x20;july2004.pdf&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Jmescriba</name></author>
	</entry>
	<entry>
		<id>https://rthwiki.iconcologia.net/index.php?title=Criteris_d%E2%80%99inclusi%C3%B3_de_l%E2%80%99RTH_ICO-ICS&amp;diff=1834&amp;oldid=prev</id>
		<title>Jmescriba a 13:44, 23 feb 2026</title>
		<link rel="alternate" type="text/html" href="https://rthwiki.iconcologia.net/index.php?title=Criteris_d%E2%80%99inclusi%C3%B3_de_l%E2%80%99RTH_ICO-ICS&amp;diff=1834&amp;oldid=prev"/>
		<updated>2026-02-23T13:44:28Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;ca&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Versió més antiga&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revisió del 13:44, 23 feb 2026&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l9&quot;&gt;Línia 9:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Línia 9:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;#*b) Pelvis renal, urèter, bufeta de l’orina i uretra. En aquestes localitzacions s&amp;#039;inclouran també histologies amb comportament &amp;#039;&amp;#039;&amp;#039;&amp;#039;&amp;#039;in situ&amp;#039;&amp;#039;&amp;#039;&amp;#039;&amp;#039; (2) (veure &amp;#039;&amp;#039;&amp;#039;[[Criteris d’inclusió de l’RTH ICO-ICS#link2|criteris d&amp;#039;inclusió dels tumors amb comportament &amp;#039;&amp;#039;in situ&amp;#039;&amp;#039;).]]&amp;#039;&amp;#039;&amp;#039;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;#*b) Pelvis renal, urèter, bufeta de l’orina i uretra. En aquestes localitzacions s&amp;#039;inclouran també histologies amb comportament &amp;#039;&amp;#039;&amp;#039;&amp;#039;&amp;#039;in situ&amp;#039;&amp;#039;&amp;#039;&amp;#039;&amp;#039; (2) (veure &amp;#039;&amp;#039;&amp;#039;[[Criteris d’inclusió de l’RTH ICO-ICS#link2|criteris d&amp;#039;inclusió dels tumors amb comportament &amp;#039;&amp;#039;in situ&amp;#039;&amp;#039;).]]&amp;#039;&amp;#039;&amp;#039;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;#*c) Neoplàsies hematològiques. Qualsevol histologia amb comportament &amp;#039;&amp;#039;&amp;#039;incert (/1)&amp;#039;&amp;#039;&amp;#039; es pot registrar&amp;#039;&amp;#039;&amp;#039;.&amp;#039;&amp;#039;&amp;#039;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;#*c) Neoplàsies hematològiques. Qualsevol histologia amb comportament &amp;#039;&amp;#039;&amp;#039;incert (/1)&amp;#039;&amp;#039;&amp;#039; es pot registrar&amp;#039;&amp;#039;&amp;#039;.&amp;#039;&amp;#039;&amp;#039;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-added&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-added&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;#039;&amp;#039;&amp;#039;Criteris d’inclusió dels tumors amb comportament &amp;#039;&amp;#039;benigne&amp;#039;&amp;#039; (0)&amp;#039;&amp;#039;&amp;#039;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;#039;&amp;#039;&amp;#039;Criteris d’inclusió dels tumors amb comportament &amp;#039;&amp;#039;benigne&amp;#039;&amp;#039; (0)&amp;#039;&amp;#039;&amp;#039;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l92&quot;&gt;Línia 92:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Línia 90:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;==&amp;lt;big&amp;gt;Definició de tumors múltiples: normes de registre&amp;lt;/big&amp;gt;==&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;==&amp;lt;big&amp;gt;Definició de tumors múltiples: normes de registre&amp;lt;/big&amp;gt;==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt; &lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;IMPORTANT !!: &#039;&#039;&#039;Els tumors urotelials múltiples de les vies urinàries (C65-C68), els tumors múltiples del Sistema Nerviós Central i les neoplàsies hematològiques múltiples segueixen unes recomanaciones especifiques d&#039;enregistrament que podeu consultar a la pàgina web de la ENCR.   &amp;lt;br /&amp;gt;&#039;&#039;&#039;&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;L’RTH registra tumors i els assigna un identificador. L’identificador de pacient permet saber si un pacient presenta un tumor o més (tumors múltiples). Els tumors múltiples segueixen la normativa de la IARC:&amp;lt;ref name=&amp;quot;:12&amp;quot;&amp;gt;International Agency for Research on Cancer, World Health Organization, International Association of Cancer Registries, European Network of Cancer Registries. &amp;#039;&amp;#039;International Rules for Multiple Primary Cancers (ICD-O Third Edition)&amp;#039;&amp;#039;. International Agency for the Research on Cancer; 2004. http://www.iacr.com.fr/images/doc/MPrules_&amp;amp;#x20;july2004.pdf&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;L’RTH registra tumors i els assigna un identificador. L’identificador de pacient permet saber si un pacient presenta un tumor o més (tumors múltiples). Els tumors múltiples segueixen la normativa de la IARC:&amp;lt;ref name=&amp;quot;:12&amp;quot;&amp;gt;International Agency for Research on Cancer, World Health Organization, International Association of Cancer Registries, European Network of Cancer Registries. &amp;#039;&amp;#039;International Rules for Multiple Primary Cancers (ICD-O Third Edition)&amp;#039;&amp;#039;. International Agency for the Research on Cancer; 2004. http://www.iacr.com.fr/images/doc/MPrules_&amp;amp;#x20;july2004.pdf&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Jmescriba</name></author>
	</entry>
	<entry>
		<id>https://rthwiki.iconcologia.net/index.php?title=Criteris_d%E2%80%99inclusi%C3%B3_de_l%E2%80%99RTH_ICO-ICS&amp;diff=1789&amp;oldid=prev</id>
		<title>Jmescriba a 09:16, 12 feb 2025</title>
		<link rel="alternate" type="text/html" href="https://rthwiki.iconcologia.net/index.php?title=Criteris_d%E2%80%99inclusi%C3%B3_de_l%E2%80%99RTH_ICO-ICS&amp;diff=1789&amp;oldid=prev"/>
		<updated>2025-02-12T09:16:44Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;ca&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Versió més antiga&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revisió del 09:16, 12 feb 2025&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l12&quot;&gt;Línia 12:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Línia 12:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&#039;&#039;&#039;Criteris d’inclusió dels tumors &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;del sistema nerviós central&lt;/del&gt;&#039;&#039;&#039;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&#039;&#039;&#039;Criteris d’inclusió dels tumors &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;amb comportament &#039;&#039;benigne&#039;&#039; (0)&lt;/ins&gt;&#039;&#039;&#039;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{| class=&amp;quot;wikitable&amp;quot;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{| class=&amp;quot;wikitable&amp;quot;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|&amp;#039;&amp;#039;&amp;#039;Descripció de la localització&amp;#039;&amp;#039;&amp;#039;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|&amp;#039;&amp;#039;&amp;#039;Descripció de la localització&amp;#039;&amp;#039;&amp;#039;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Jmescriba</name></author>
	</entry>
	<entry>
		<id>https://rthwiki.iconcologia.net/index.php?title=Criteris_d%E2%80%99inclusi%C3%B3_de_l%E2%80%99RTH_ICO-ICS&amp;diff=1788&amp;oldid=prev</id>
		<title>Jmescriba a 07:51, 12 feb 2025</title>
		<link rel="alternate" type="text/html" href="https://rthwiki.iconcologia.net/index.php?title=Criteris_d%E2%80%99inclusi%C3%B3_de_l%E2%80%99RTH_ICO-ICS&amp;diff=1788&amp;oldid=prev"/>
		<updated>2025-02-12T07:51:19Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;ca&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Versió més antiga&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revisió del 07:51, 12 feb 2025&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l1&quot;&gt;Línia 1:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Línia 1:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;div id=link01&amp;gt; &amp;lt;/div&amp;gt;&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-added&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;==&amp;lt;big&amp;gt;Definició de cas&amp;lt;/big&amp;gt;==&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;==&amp;lt;big&amp;gt;Definició de cas&amp;lt;/big&amp;gt;==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-added&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-added&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;S’inclouen a l’RTH els tumors diagnosticats i/o tractats al centre de l’RTH en el període d’estudi. Criteris d’inclusió:&amp;lt;ref name=&amp;quot;:0&amp;quot;&amp;gt;International Agency for Research on Cancer. &amp;#039;&amp;#039;Standards and Guidelines for Cancer Registration in Europe. The ENCR Recommendations.&amp;#039;&amp;#039; Vol I. (Tyczynski J, Démaret E, Parkin D, ed.). IARC Technical Publication No. 40; 2003. http://www.&amp;amp;#x20;iarc.fr/en/publications/pdfs-online/treport-pub/treport-pub40/index.php&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;:1&amp;quot;&amp;gt;Martos C, Crocetti E, Visser O, Rous B, Cancer Data Quality Checks Working Group. &amp;#039;&amp;#039;A Proposal on Cancer Data Quality Checks : One Common Procedure for European Cancer Registries&amp;#039;&amp;#039;. European Network of Cancer Registries; 2018. doi:10.2760/429053&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;:8&amp;quot;&amp;gt;International Agency for Research on Cancer, World Health Organization, International Association of Cancer Registries. &amp;#039;&amp;#039;Cancer Registration: Principles and Methods&amp;#039;&amp;#039;. (Jensen O, Parkin D, Maclennan R, Muir C, Skeet R, ed.). IARC Scientific Publications No, 95; 1991. https://publications.iarc.fr/Book-And-Report-Series/Iarc-Scientific-Publications/&amp;amp;#x20;Cancer-Registration-Principles-And-Methods-1991&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;S’inclouen a l’RTH els tumors diagnosticats i/o tractats al centre de l’RTH en el període d’estudi. Criteris d’inclusió:&amp;lt;ref name=&amp;quot;:0&amp;quot;&amp;gt;International Agency for Research on Cancer. &amp;#039;&amp;#039;Standards and Guidelines for Cancer Registration in Europe. The ENCR Recommendations.&amp;#039;&amp;#039; Vol I. (Tyczynski J, Démaret E, Parkin D, ed.). IARC Technical Publication No. 40; 2003. http://www.&amp;amp;#x20;iarc.fr/en/publications/pdfs-online/treport-pub/treport-pub40/index.php&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;:1&amp;quot;&amp;gt;Martos C, Crocetti E, Visser O, Rous B, Cancer Data Quality Checks Working Group. &amp;#039;&amp;#039;A Proposal on Cancer Data Quality Checks : One Common Procedure for European Cancer Registries&amp;#039;&amp;#039;. European Network of Cancer Registries; 2018. doi:10.2760/429053&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;:8&amp;quot;&amp;gt;International Agency for Research on Cancer, World Health Organization, International Association of Cancer Registries. &amp;#039;&amp;#039;Cancer Registration: Principles and Methods&amp;#039;&amp;#039;. (Jensen O, Parkin D, Maclennan R, Muir C, Skeet R, ed.). IARC Scientific Publications No, 95; 1991. https://publications.iarc.fr/Book-And-Report-Series/Iarc-Scientific-Publications/&amp;amp;#x20;Cancer-Registration-Principles-And-Methods-1991&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Jmescriba</name></author>
	</entry>
	<entry>
		<id>https://rthwiki.iconcologia.net/index.php?title=Criteris_d%E2%80%99inclusi%C3%B3_de_l%E2%80%99RTH_ICO-ICS&amp;diff=1787&amp;oldid=prev</id>
		<title>Jmescriba a 07:50, 12 feb 2025</title>
		<link rel="alternate" type="text/html" href="https://rthwiki.iconcologia.net/index.php?title=Criteris_d%E2%80%99inclusi%C3%B3_de_l%E2%80%99RTH_ICO-ICS&amp;diff=1787&amp;oldid=prev"/>
		<updated>2025-02-12T07:50:20Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;ca&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Versió més antiga&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revisió del 07:50, 12 feb 2025&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l12&quot;&gt;Línia 12:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Línia 12:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;#*b) Pelvis renal, urèter, bufeta de l’orina i uretra. En aquestes localitzacions s&amp;#039;inclouran també histologies amb comportament &amp;#039;&amp;#039;&amp;#039;&amp;#039;&amp;#039;in situ&amp;#039;&amp;#039;&amp;#039;&amp;#039;&amp;#039; (2) (veure &amp;#039;&amp;#039;&amp;#039;[[Criteris d’inclusió de l’RTH ICO-ICS#link2|criteris d&amp;#039;inclusió dels tumors amb comportament &amp;#039;&amp;#039;in situ&amp;#039;&amp;#039;).]]&amp;#039;&amp;#039;&amp;#039;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;#*b) Pelvis renal, urèter, bufeta de l’orina i uretra. En aquestes localitzacions s&amp;#039;inclouran també histologies amb comportament &amp;#039;&amp;#039;&amp;#039;&amp;#039;&amp;#039;in situ&amp;#039;&amp;#039;&amp;#039;&amp;#039;&amp;#039; (2) (veure &amp;#039;&amp;#039;&amp;#039;[[Criteris d’inclusió de l’RTH ICO-ICS#link2|criteris d&amp;#039;inclusió dels tumors amb comportament &amp;#039;&amp;#039;in situ&amp;#039;&amp;#039;).]]&amp;#039;&amp;#039;&amp;#039;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;#*c) Neoplàsies hematològiques. Qualsevol histologia amb comportament &amp;#039;&amp;#039;&amp;#039;incert (/1)&amp;#039;&amp;#039;&amp;#039; es pot registrar&amp;#039;&amp;#039;&amp;#039;.&amp;#039;&amp;#039;&amp;#039;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;#*c) Neoplàsies hematològiques. Qualsevol histologia amb comportament &amp;#039;&amp;#039;&amp;#039;incert (/1)&amp;#039;&amp;#039;&amp;#039; es pot registrar&amp;#039;&amp;#039;&amp;#039;.&amp;#039;&amp;#039;&amp;#039;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;#039;&amp;#039;&amp;#039;Criteris d’inclusió dels tumors del sistema nerviós central&amp;#039;&amp;#039;&amp;#039;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;#039;&amp;#039;&amp;#039;Criteris d’inclusió dels tumors del sistema nerviós central&amp;#039;&amp;#039;&amp;#039;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Jmescriba</name></author>
	</entry>
	<entry>
		<id>https://rthwiki.iconcologia.net/index.php?title=Criteris_d%E2%80%99inclusi%C3%B3_de_l%E2%80%99RTH_ICO-ICS&amp;diff=1786&amp;oldid=prev</id>
		<title>Jmescriba a 07:50, 12 feb 2025</title>
		<link rel="alternate" type="text/html" href="https://rthwiki.iconcologia.net/index.php?title=Criteris_d%E2%80%99inclusi%C3%B3_de_l%E2%80%99RTH_ICO-ICS&amp;diff=1786&amp;oldid=prev"/>
		<updated>2025-02-12T07:50:06Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;ca&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Versió més antiga&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revisió del 07:50, 12 feb 2025&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l13&quot;&gt;Línia 13:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Línia 13:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;#*c) Neoplàsies hematològiques. Qualsevol histologia amb comportament &amp;#039;&amp;#039;&amp;#039;incert (/1)&amp;#039;&amp;#039;&amp;#039; es pot registrar&amp;#039;&amp;#039;&amp;#039;.&amp;#039;&amp;#039;&amp;#039;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;#*c) Neoplàsies hematològiques. Qualsevol histologia amb comportament &amp;#039;&amp;#039;&amp;#039;incert (/1)&amp;#039;&amp;#039;&amp;#039; es pot registrar&amp;#039;&amp;#039;&amp;#039;.&amp;#039;&amp;#039;&amp;#039;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt; &lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&#039;&#039;&#039;Criteris d’inclusió dels tumors del sistema nerviós central&#039;&#039;&#039;&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{| class=&amp;quot;wikitable&amp;quot;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{| class=&amp;quot;wikitable&amp;quot;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|&amp;#039;&amp;#039;&amp;#039;Descripció de la localització&amp;#039;&amp;#039;&amp;#039;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|&amp;#039;&amp;#039;&amp;#039;Descripció de la localització&amp;#039;&amp;#039;&amp;#039;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Jmescriba</name></author>
	</entry>
</feed>